A detailed history of Occidental Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Occidental Asset Management, LLC holds 7,343 shares of ABBV stock, worth $1.24 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
7,343
Previous 7,990 8.1%
Holding current value
$1.24 Million
Previous $1.58 Million 17.31%
% of portfolio
0.2%
Previous 0.26%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

SELL
$164.99 - $203.87 $106,748 - $131,903
-647 Reduced 8.1%
7,343 $1.3 Million
Q3 2024

Oct 11, 2024

BUY
$163.84 - $199.33 $87,982 - $107,040
537 Added 7.21%
7,990 $1.58 Million
Q2 2024

Jul 15, 2024

BUY
$154.79 - $180.76 $18,110 - $21,148
117 Added 1.59%
7,453 $1.28 Million
Q1 2024

Apr 16, 2024

BUY
$159.82 - $182.1 $148,153 - $168,806
927 Added 14.46%
7,336 $1.34 Million
Q4 2023

Jan 18, 2024

SELL
$137.6 - $154.97 $11,971 - $13,482
-87 Reduced 1.34%
6,409 $993,000
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $5,076 - $5,876
38 Added 0.59%
6,496 $968,000
Q2 2023

Jul 11, 2023

BUY
$132.51 - $164.9 $18,153 - $22,591
137 Added 2.17%
6,458 $870,000
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $6,796 - $7,827
-47 Reduced 0.74%
6,321 $1.01 Million
Q4 2022

Jan 23, 2023

BUY
$138.31 - $165.87 $346,881 - $416,001
2,508 Added 64.97%
6,368 $0
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $16,776 - $19,241
125 Added 3.35%
3,860 $518,000
Q2 2022

Jul 18, 2022

BUY
$137.62 - $174.96 $18,578 - $23,619
135 Added 3.75%
3,735 $572,000
Q1 2022

May 04, 2022

BUY
$131.98 - $163.75 $13,197 - $16,375
100 Added 2.86%
3,600 $584,000
Q1 2021

May 06, 2021

SELL
$102.3 - $112.62 $1.19 Million - $1.31 Million
-11,607 Reduced 76.83%
3,500 $379,000
Q4 2020

Jan 28, 2021

BUY
$80.49 - $108.67 $60,367 - $81,502
750 Added 5.22%
15,107 $1.62 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $4,467 - $5,243
52 Added 0.36%
14,357 $1.26 Million
Q2 2020

Jul 17, 2020

BUY
$73.37 - $98.18 $94,500 - $126,455
1,288 Added 9.89%
14,305 $1.4 Million
Q1 2020

Apr 23, 2020

BUY
$64.5 - $97.79 $127,581 - $193,428
1,978 Added 17.92%
13,017 $992,000
Q4 2019

Jan 16, 2020

BUY
$72.13 - $90.25 $57,199 - $71,568
793 Added 7.74%
11,039 $977,000
Q3 2019

Oct 17, 2019

BUY
$62.98 - $75.72 $162,551 - $195,433
2,581 Added 33.67%
10,246 $776,000
Q2 2019

Aug 02, 2019

BUY
$65.7 - $83.98 $80,876 - $103,379
1,231 Added 19.13%
7,665 $557,000
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $496,318 - $584,142
6,434 New
6,434 $519,000
Q2 2018

Mar 19, 2019

SELL
$89.78 - $106.23 $215,472 - $254,952
-2,400 Closed
0 $0
Q3 2017

Mar 19, 2019

BUY
$69.85 - $89.22 $167,640 - $214,128
2,400
2,400 $213,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $299B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Occidental Asset Management, LLC Portfolio

Follow Occidental Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occidental Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Occidental Asset Management, LLC with notifications on news.